Softwr

Research · head to head

Castor EDC vs Genedata

Castor EDC logo

Castor EDC

Research

Electronic data capture and eConsent for clinical trials, built for investigator-initiated studies as well as sponsors

From
On request
Rated
-
Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-

The short version

  • Each has a real cost: Castor EDC nothing is published: pricing is quoted only after a scoping call and protocol review, so budgeting a grant application means asking for a quote months before the study is funded and hoping the scope holds.; Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • They diverge on capability: Castor EDC covers Browser-based study build, Genedata covers Screener.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Castor EDC and Genedata actually diverge.

Attributes where Castor EDC and Genedata differ
AttributeCastor EDCGenedata
PlatformsWeb, iOS, AndroidWeb, On-premise, Private cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Castor EDC

  • Browser-based study build
  • 21 CFR Part 11 workflows
  • eConsent
  • ePRO and surveys
  • Randomisation
  • Per-study licensing
  • Grant-funded pricing paths
  • Data export

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

What people use each for

The jobs each tool is most often brought in to do.

Castor EDC

  • An academic hospital running an investigator-initiated trial that cannot fund a sponsor-grade EDC contract or a data management CROnot Genedata
  • A medical device company collecting post-market clinical follow-up data with Part 11 audit trailsnot Genedata
  • A multi-site registry that needs remote eConsent because participants are recruited nationally rather than at a clinicnot Genedata
  • A biotech running a small phase two study that wants the database built by its own clinical team in weeks rather than commissionednot Genedata

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Castor EDC
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Castor EDC
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Castor EDC
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Castor EDC

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Castor EDC

  • Nothing is published: pricing is quoted only after a scoping call and protocol review, so budgeting a grant application means asking for a quote months before the study is funded and hoping the scope holds.
  • Price scales on protocol complexity rather than a simple unit, so two studies with the same participant count can be quoted very differently and there is no public benchmark to argue against.
  • Modules such as eConsent, ePRO and randomisation are quoted on top of the base platform, so the headline EDC figure is rarely the number that appears on the final proposal.
  • It is deliberately lighter than the full sponsor suites, so a study that grows into a global registrational programme needing integrated CTMS, safety, IRT and full trial supply management will need additional systems and the interfaces between them.
  • Regulatory responsibility does not transfer with the software: the platform supports Part 11 compliant workflows, but system validation for your intended use, SOPs and audit readiness remain your obligation and your cost, which sponsors new to EDC consistently underestimate.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

Pricing, plan by plan

Castor EDC

On request
  • Castor EDC$undefined/year
    • Priced per study on protocol complexity, duration, sites and modules
    • 21 CFR Part 11 and ICH GCP workflows
    • eConsent, ePRO and randomisation modules quoted separately

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Which should you pick?

Choose Castor EDC if

  • You need browser-based study build.
  • You work on Web, iOS, Android.
  • You also want 21 cfr part 11 workflows.

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.

Questions people ask

Is Castor EDC or Genedata better?
Neither clearly leads. Castor EDC starts at On request and Genedata at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Castor EDC or Genedata?
Castor EDC starts at On request and Genedata at On request.
Does Castor EDC or Genedata run on more platforms?
Castor EDC runs on Web, iOS, Android. Genedata runs on Web, On-premise, Private cloud.
What is Castor EDC best used for?
Castor EDC is most often used for an academic hospital running an investigator-initiated trial that cannot fund a sponsor-grade edc contract or a data management cro, a medical device company collecting post-market clinical follow-up data with part 11 audit trails, a multi-site registry that needs remote econsent because participants are recruited nationally rather than at a clinic, a biotech running a small phase two study that wants the database built by its own clinical team in weeks rather than commissioned. Of those, an academic hospital running an investigator-initiated trial that cannot fund a sponsor-grade edc contract or a data management cro and a medical device company collecting post-market clinical follow-up data with part 11 audit trails are not what Genedata is typically brought in for.
What can Castor EDC do that Genedata cannot?
Castor EDC covers Browser-based study build, 21 CFR Part 11 workflows, eConsent, ePRO and surveys. Genedata covers Screener, Biologics, Bioprocess, Expressionist.

Answered from the vendors’ own pages

Castor EDC: Is there a free academic version?

No published free tier. There are academic, non-profit and grant-funded pricing paths, but each is quoted rather than self-service.

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Castor EDC: Is it 21 CFR Part 11 compliant?

It supports Part 11 compliant workflows with audit trails and electronic signatures. Validating the system for your specific use remains your responsibility.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Castor EDC: Do I need a programmer to build a study?

No. Case report forms are configured in the browser, which is the main reason academic groups adopt it.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Castor EDC: How long does a quote take?

Castor states a full pricing proposal within five business days of sharing the protocol.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Share

Related pages

Other head to heads